ADVERTISEMENT

Artificial Intelligence

Digital Health Roundup: GE HealthCare On AI At HLTH; Medtech Conference Panel; Graphene Brain Implant; Unicorns & More

Digital Health Roundup: GE HealthCare On AI At HLTH; Medtech Conference Panel; Graphene Brain Implant; Unicorns & More

In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb talks about her interview with GE HealthCare’s chief AI officer Parminder Bhatia about his vision for AI in health care and other highlights from HLTH. Natasha Barrow discusses her interview with Owkin on the EU AI Act and highlights Click Therapeutics’ latest clinical results.

How To Speed Up MLR Reviews, Cut Risk: A Master Class By J&J, UCB, ex-Takeda Heads

How To Speed Up MLR Reviews, Cut Risk: A Master Class By J&J, UCB, ex-Takeda Heads

A panel of experts from J&J, UCB and Takeda deliberated on the use of AI and internal processes to strike the right balance between speed and accuracy in MLR reviews that could protect a company from serious repercussions. They also spoke of the need for regulatory systems to catch up.

How To Speed Up MLR Reviews: A Master Class By J&J, UCB, ex-Takeda Heads

How To Speed Up MLR Reviews: A Master Class By J&J, UCB, ex-Takeda Heads

A panel of experts from J&J, UCB and Takeda deliberated on the use of AI and internal processes to strike the right balance between speed and accuracy in MLR reviews that could protect a company from serious repercussions

Korea Lays Out Roadmap For Use Of AI Across Drug Development

Korea Lays Out Roadmap For Use Of AI Across Drug Development

The five-year roadmap aims to expand support for AI research and development in essential health care and new drug development, as well as advance medical data usage systems and enable its safe use.

HLTH 2024: GE HealthCare’s Chief AI Officer Says Future Of AI No Longer A Black Box

HLTH 2024: GE HealthCare’s Chief AI Officer Says Future Of AI No Longer A Black Box

Medtech Insight talked with GE HealthCare’s chief AI officer Parminder “Parry” Bhatia at HLTH about the firm’s new CareIntellect for Oncology offering to help clinicians make efficient use of multimodal patient data, his vision for projects within AI Innovation Lab, and the future of AI in health care.

Beta Bionics Launches iLet Bionic Pancreas With Abbott’s Latest-Generation CGM

Beta Bionics Launches iLet Bionic Pancreas With Abbott’s Latest-Generation CGM

Beta Bionics’ automated insulin delivery system is now pairable with Abbott’s FreeStyle Libre 3 Plus CGM.

HLTH 2024: GE HealthCare Unveiled AI-Driven Platform To Quickly Provide Patient Data To Oncologists

HLTH 2024: GE HealthCare Unveiled AI-Driven Platform To Quickly Provide Patient Data To Oncologists

At HLTH 2024, GE HealthCare unveiled CareIntellect for Oncology, a generative AI-driven platform to help oncologists quickly assess patient data across multiple sources to save time and improve treatment planning. The platform, currently in evaluation at two US hospitals, is set for launch in the second half of 2025.

Google’s New Drug Discovery And Development LLM

Google’s New Drug Discovery And Development LLM

A new large language model by Google Research and DeepMind is the most comprehensive tool yet to potentially expedite drug development and reduce the risk of failure.

7 Start-Ups At HLTH 2024: Shaking Up Medtech’s Business Model, ‘AI’ For Cancer Detection, MCI Assessment, Validation, Monitoring

7 Start-Ups At HLTH 2024: Shaking Up Medtech’s Business Model, ‘AI’ For Cancer Detection, MCI Assessment, Validation, Monitoring

Medtech Insight was on the ground at HLTH looking for innovative companies. Learn about seven start-ups using AI to help physicians detect conditions including prostate and breast cancers, seizures and heart failure; assess patients for cognitive decline validate and deploy algorithms, and monitor patients in and out of the hospital.

Quotable: Top Experts On Policy Hot Topics

Quotable: Top Experts On Policy Hot Topics

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.